A Pharmacokinetic Study of MABp1 in Healthy Volunteers
|2||Active, not recruiting||
A Phase 3 Study to Evaluate Xilonix as an Anticancer Therapy in Patients With Symptomatic Colorectal Cancer
A Phase II Open Label Study of Xilonix in Subjects With Pyoderma Gangrenosum
A Study of the Safety and Efficacy of 514G3 in Subjects Hospitalized With Bacteremia Due to Staphylococcus Aureus
Phase II Trial of RA-18C3 in Subjects With Moderate to Severe Acne Vulgaris
|6||Active, not recruiting||
A Phase III Study of Xilonix in Patients With Advanced Colorectal Cancer
A Study of the Safety and Pharmacokinetics of an Anti-Inflammatory Therapeutic Antibody (MABp1) in Patients With Type 2 Diabetes
Safety, Pharmacokinetics, and Efficacy of RA-18C3 in Subjects With Moderate to Severe Psoriasis
Safety and Preliminary Efficacy Study of an Anti-inflammatory Therapeutic Antibody in Reducing Restenosis.
Study of CA-18C3 in Subjects With Advanced Hematologic Malignancies
A First in Man Study of MABp1 in Patients With Advanced Cancers
† Study has passed its completion date and status has not been verified in more than two years.